Concepedia

Xiaoshen Dong

XD

Statistics

Publications

7

Citations

231

H-Index

7

Active since

2012

Affiliations

China Medical University(Current)

First Hospital of China Medical University

Fox Chase Cancer Center

Obstetrics and Gynecology Hospital of Fudan University

Xiaoshen Dong is an author at China Medical University specializing in oncology, molecular oncology, and medicine.

Publications per year

2012–2022

7

Publications

7

Blockade of the immunosuppressive KIR2DL5/PVR pathway elicits potent human NK cell–mediated antitumor immunity

Xiaoxin Ren, Mou Peng, Xing Peng et al. · Journal of Clinical Investigation · 2022 · 53 citations · Full text

, , +16

LncRNA NONHSAT141924 promotes paclitaxel chemotherapy resistance through p-CREB/Bcl-2 apoptosis signaling pathway in breast cancer

Ming Gu, Wenhui Zheng, Mingdi Zhang et al. · Journal of Cancer · 2020 · 44 citations · Full text

, , +17

Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis

Xiaoshen Dong, R. Katherine Alpaugh, Massimo Cristofanilli · Chinese Journal of Cancer Research · 2012 · 35 citations · Full text

, , +17

Downregulation of RAI14 inhibits the proliferation and invasion of breast cancer cells

Ming Gu, Wenhui Zheng, Mingdi Zhang et al. · Journal of Cancer · 2019 · 30 citations · Full text

, , +17

Gli1 promotes transforming growth factor-beta1– and epidermal growth factor–induced epithelial to mesenchymal transition in pancreatic cancer cells

Qingfeng Liu, Weiwei Sheng, Ming Dong et al. · Surgery · 2015 · 26 citations

, , +13

1–5 of 7